Form D — Vergent Bioscience, Inc.
0001741495-25-000004 · filed Oct 20, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $31,957,273
- Reported amount sold
- $18,673,277
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vergent Bioscience, Inc.
- CIK
- 1741495
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5810 W 78TH ST
MINNEAPOLIS, Minnesota 55439 - Phone
- 9524263772
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John T. Santini, Jr. · Executive OfficerMinneapolis, Minnesota Find on LinkedIn ↗
-
Douglas Kohrs · DirectorMinneapolis, Minnesota Find on LinkedIn ↗
-
Raymond Wong · DirectorMinneapolis, Minnesota Find on LinkedIn ↗
-
Bobby Helmedag · DirectorMinneapolis, Minnesota Find on LinkedIn ↗
-
Anita Watkins · DirectorMinneapolis, Minnesota Find on LinkedIn ↗
-
Jeffrey Yurecko · Executive OfficerMinneapolis, Minnesota Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗